These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34343674)

  • 1. Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result.
    Pitlick MM; Park MA; Gonzalez-Estrada A; Chiarella SE
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):498-499. PubMed ID: 34343674
    [No Abstract]   [Full Text] [Related]  

  • 2. Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.
    Abi Zeid Daou C; Natout MA; El Hadi N
    J Med Virol; 2021 Oct; 93(10):6027-6029. PubMed ID: 34050949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation.
    Erdeljic Turk V
    Clin Immunol; 2021 Jun; 227():108748. PubMed ID: 33932618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: Early report.
    Pitlick MM; Sitek AN; Kinate SA; Joshi AY; Park MA
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):735-738. PubMed ID: 33775902
    [No Abstract]   [Full Text] [Related]  

  • 5. Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.
    Murphy KR; Patel NC; Ein D; Hudelson M; Kodoth S; Marshall GD; Parikh P; Blaiss MS
    Ann Allergy Asthma Immunol; 2021 Apr; 126(4):319-320. PubMed ID: 33493641
    [No Abstract]   [Full Text] [Related]  

  • 6. Maintaining Safety with SARS-CoV-2 Vaccines.
    Castells MC; Phillips EJ
    N Engl J Med; 2021 Feb; 384(7):643-649. PubMed ID: 33378605
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients.
    Bloomfield M; Parackova Z; Hanzlikova J; Lastovicka J; Sediva A
    J Clin Immunol; 2022 Feb; 42(2):266-269. PubMed ID: 34718945
    [No Abstract]   [Full Text] [Related]  

  • 8. Safe Administration of SARS-CoV-2 Vaccine After Desensitization to a Biologic Containing Polysorbate 80 in a Patient With Polyethylene Glycol-Induced Severe Anaphylaxis and Sensitization to Polysorbate 80.
    Nin-Valencia A; Fiandor A; Lluch M; Quirce S; Caballero T; Heredia Revuelto R; González-Muñoz M; Caballero ML; Cabañas R
    J Investig Allergol Clin Immunol; 2023 Apr; 33(2):151-153. PubMed ID: 35638393
    [No Abstract]   [Full Text] [Related]  

  • 9. Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy.
    Soeiro T; Salvo F; Pariente A; Grandvuillemin A; Jonville-Béra AP; Micallef J
    Therapie; 2021; 76(4):365-367. PubMed ID: 33858693
    [No Abstract]   [Full Text] [Related]  

  • 10. Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
    Azenha Rama T; Álvarez-Twose I
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):193-195. PubMed ID: 33574015
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of mRNA-Based Vaccines for SARS CoV-2.
    Barda B; Cerny A
    Chem Res Toxicol; 2021 Aug; 34(8):1823-1825. PubMed ID: 34009959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.
    Risma KA; Edwards KM; Hummell DS; Little FF; Norton AE; Stallings A; Wood RA; Milner JD
    J Allergy Clin Immunol; 2021 Jun; 147(6):2075-2082.e2. PubMed ID: 33857566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
    Moghimi SM
    Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccination hesitancy and the "myth" on mRNA-based vaccines in Italy in the COVID-19 era: Does urgency meet major safety criteria?
    Chirumbolo S
    J Med Virol; 2021 Jul; 93(7):4049-4053. PubMed ID: 33666240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How COVID unlocked the power of RNA vaccines.
    Dolgin E
    Nature; 2021 Jan; 589(7841):189-191. PubMed ID: 33437061
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
    Rojas-Pérez-Ezquerra P; Crespo Quirós J; Tornero Molina P; Baeza Ochoa de Ocáriz ML; Zubeldia Ortuño JM
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):180-181. PubMed ID: 33648905
    [No Abstract]   [Full Text] [Related]  

  • 17. The COVID vaccine pioneer behind southeast Asia's first mRNA shot.
    Mallapaty S
    Nature; 2021 Jun; 594(7862):163. PubMed ID: 34040244
    [No Abstract]   [Full Text] [Related]  

  • 18. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.
    Wang M; Wen W; Zhou M; Wang C; Feng ZH
    Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
    Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT
    Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype.
    Pascolo S
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33572452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.